Evidence map›Paper›PMID 30108154›Full record

ArticleJournal of lipid research2018

Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice.

Jens Madsen, Madhuriben H Panchal, Rose-Marie A Mackay, Mercedes Echaide, Grielof Koster, Giancarlo Aquino, Nicola Pelizzi, Jesus Perez-Gil, Fabrizio Salomone, Howard W Clark and 1 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Pulmonary Surfactants: a New Therapeutic Target in Asthma.Current allergy and asthma reports · 2020
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Jens MadsenChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.ORCID 0000-0001-7361-0756
Madhuriben H PanchalChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Rose-Marie A MackayChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Mercedes EchaideDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Hospital 12 de Octubre Research Institute, Complutense University, Madrid, Spain.ORCID 0000-0002-0836-0858
Grielof KosterChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Giancarlo AquinoChiesi Farmaceutici SpA, Parma, Italy.
Nicola PelizziChiesi Farmaceutici SpA, Parma, Italy.
Jesus Perez-GilDepartment of Biochemistry and Molecular Biology, Faculty of Biology, Hospital 12 de Octubre Research Institute, Complutense University, Madrid, Spain.ORCID 0000-0003-3587-7147
Fabrizio SalomoneChiesi Farmaceutici SpA, Parma, Italy.
Howard W ClarkChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Anthony D PostleChild Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom adp@soton.ac.uk.
University of Southampton · GBChiesi (Italy) · ITResearch Institute Hospital 12 de Octubre · ESNational Institute for Health Research · GBUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Secreted pulmonary surfactant phosphatidylcholine (PC) has a complex intra-alveolar metabolism that involves uptake and recycling by alveolar type II epithelial cells, catabolism by alveolar macrophages, and loss up the bronchial tree. We compared the in vivo metabolism of animal-derived poractant alfa (Curosurf) and a synthetic surfactant (CHF5633) in adult male C57BL/6 mice. The mice were dosed intranasally with either surfactant (80 mg/kg body weight) containing universally

Indexed as

AnimalsBiological ProductsLungMaleMiceMice, Inbred C57BLPeptide FragmentsPhosphatidylcholinesPhospholipidsPulmonary Surfactant-Associated Protein BPulmonary Surfactant-Associated Protein CPulmonary SurfactantsBiological ProductsCHF5633Peptide FragmentsPhosphatidylcholinesPhospholipidsporactant alfaPulmonary Surfactant-Associated Protein BPulmonary Surfactant-Associated Protein CPulmonary Surfactantsacyl remodelingmass spectrometrymolecular speciesphosphatidylcholine synthesisstable isotopes

Identifiers

PMID30108154
PMCPMC6168297
OpenAlexW2885283225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.